MX26267A - Aminobenzodiacepinas y procedimiento para su prepaacion. - Google Patents

Aminobenzodiacepinas y procedimiento para su prepaacion.

Info

Publication number
MX26267A
MX26267A MX2626791A MX2626791A MX26267A MX 26267 A MX26267 A MX 26267A MX 2626791 A MX2626791 A MX 2626791A MX 2626791 A MX2626791 A MX 2626791A MX 26267 A MX26267 A MX 26267A
Authority
MX
Mexico
Prior art keywords
aminobenzodiacepinas
procedure
preparation
Prior art date
Application number
MX2626791A
Other languages
English (en)
Inventor
Anne Roberte Bellemin
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of MX26267A publication Critical patent/MX26267A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
MX2626791A 1990-06-18 1991-06-17 Aminobenzodiacepinas y procedimiento para su prepaacion. MX26267A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/539,500 US5141735A (en) 1990-06-18 1990-06-18 Substituted amino-benzodiazepines having anitviral activity

Publications (1)

Publication Number Publication Date
MX26267A true MX26267A (es) 1993-09-01

Family

ID=24151485

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2626791A MX26267A (es) 1990-06-18 1991-06-17 Aminobenzodiacepinas y procedimiento para su prepaacion.

Country Status (21)

Country Link
US (1) US5141735A (es)
EP (1) EP0462522A1 (es)
JP (1) JPH04230280A (es)
KR (1) KR920000746A (es)
CN (1) CN1057462A (es)
AU (1) AU7846991A (es)
BR (1) BR9102489A (es)
CA (1) CA2044694A1 (es)
CS (1) CS182991A3 (es)
FI (1) FI912927A (es)
HU (1) HUT58069A (es)
IE (1) IE912061A1 (es)
IL (1) IL98499A0 (es)
IS (1) IS3718A7 (es)
LT (1) LTIP863A (es)
MC (1) MC2263A1 (es)
MX (1) MX26267A (es)
NO (1) NO912346L (es)
NZ (1) NZ238552A (es)
PT (1) PT98007A (es)
ZA (1) ZA914202B (es)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE253050T1 (de) 1992-03-11 2003-11-15 Narhex Ltd Aminderivate von oxo- und hydroxy- substituierten kohlenwasserstoffen
CA2130754C (en) * 1992-03-11 2005-02-08 Damian W. Grobelny Amine derivatives of oxo- and hydroxy-substituted hydrocarbons
US5888992A (en) * 1992-03-11 1999-03-30 Narhex Limited Polar substituted hydrocarbons
US6071895A (en) * 1992-03-11 2000-06-06 Narhex Limited Polar-substituted hydrocarbons
SI9300288A (sl) * 1992-06-16 1993-12-31 Hoffmann La Roche Benzodiazepini
CA2147605A1 (en) * 1992-10-23 1994-05-11 Michael R. Green Small molecule inhibition of rna/ligand binding
US5939430A (en) * 1993-02-22 1999-08-17 Merrell Pharmaceuticals Inc. Combinations of retroviral inhibitors
US5578573A (en) * 1995-01-20 1996-11-26 Houghten Pharmaceuticals, Inc. Viral integrase inhibiting peptides
CA2269078C (en) * 1996-10-16 2012-01-24 Shaman Pharmaceuticals, Inc. Enteric formulations of proanthocyanidin polymer antidiarrheal compositions
US7015212B1 (en) 1999-05-12 2006-03-21 The United States Of America As Represented By The Department Of Health And Human Services Thiazepine inhibitors of HIV-1 integrase
GB0015904D0 (en) 2000-06-28 2000-08-23 Hoffmann La Roche Inhibitors of HPV E1 helicase enzyme
US20020150541A1 (en) * 2000-09-12 2002-10-17 Gene Trol Biotherapeutics, Inc. Compositions comprising mixtures of therapeutic proteins and methods of producing the same
US20020150552A1 (en) * 2000-09-12 2002-10-17 Lau Allan S. Compositions comprising mixtures of therapeutic proteins and methods of producing the same
US20030129162A1 (en) * 2000-09-12 2003-07-10 Lau Allan S. Compositions comprising mixtures of therapeutic proteins and methods of producing the same
JP2005089298A (ja) * 2001-09-18 2005-04-07 Japan Tobacco Inc ナフタレン化合物及びその医薬用途
IL161022A0 (en) * 2001-10-05 2004-08-31 Intermune Inc Methods of treating liver fibrosis and hepatitis c virus infection
EP1691852A2 (en) * 2003-11-10 2006-08-23 Angiotech International AG Medical implants and fibrosis-inducing agents
KR100652975B1 (ko) * 2005-03-17 2006-12-01 유해일 옥수숫대 반화학 기계펄프의 제조방법
EP2685985B1 (en) 2011-03-17 2016-08-31 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Methods for treating leukemia and disorders mediated by cbf and runx1 proteins
EP3535253A1 (en) * 2016-11-01 2019-09-11 H. Hoffnabb-La Roche Ag 1,3-dihydro-1,4-benzodiazepine-2-thiones for the treatment of cns related diseases
WO2018093797A1 (en) 2016-11-15 2018-05-24 The Schepens Eye Research Institute, Inc. Compositions and methods for the treatment of aberrant angiogenesis
US11583497B2 (en) 2017-11-14 2023-02-21 The Schepens Eye Research Institute, Inc. Nano-emulsion of CBFß-RUNX1 inhibitor for ocular drug delivery
CA3082643A1 (en) 2017-11-14 2019-05-23 The Schepens Eye Research Institute, Inc. Runx1 inhibition for treatment of proliferative vitreoretinopathy and conditions associated with epithelial to mesenchymal transition

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3267110A (en) * 1960-06-03 1966-08-16 Smith Kline French Lab Trifluoromethyl substituted o-aminophenyl ketones
NL131733C (es) * 1961-06-20
NL295083A (es) * 1962-07-10
US3330481A (en) * 1965-03-18 1967-07-11 Filtra Inc Dispersant dispenser of an absorbent or adsorbent material
CH502354A (de) * 1967-03-08 1971-01-31 Hoffmann La Roche Verfahren zur Herstellung von Benzodiazepin-Derivaten
ZA698792B (en) * 1968-12-30 1971-03-31 Fujisawa Pharmaceutical Co Novel antibiotic and derivatives and production thereof
JPS4843755B1 (es) * 1969-06-26 1973-12-20
US3778433A (en) * 1969-04-18 1973-12-11 Sumitomo Chemical Co Process for producing benzodiazepine derivatives
US3954728A (en) * 1972-07-13 1976-05-04 Hoffman-La Roche Inc. Preparation of triazolo benzodiazepines and novel compounds
DE3619202A1 (de) * 1986-06-07 1987-12-10 Merz & Co Gmbh & Co Verwendung von avaron und avarol sowie von derivaten davon zur bekaempfung von aids und arc
US4788181A (en) * 1986-09-29 1988-11-29 The United States Of America As Represented By The Department Of Health And Human Services 5-substituted-2',3'-dideoxycytidine compounds with anti-HTLV-III activity
GB8806449D0 (en) * 1988-03-18 1988-04-20 Janssen Pharmaceutica Nv Antiviral hexahydroimiazo(1 4)benzodiazepin-2-ones

Also Published As

Publication number Publication date
JPH04230280A (ja) 1992-08-19
FI912927A0 (fi) 1991-06-17
FI912927A (fi) 1991-12-19
CN1057462A (zh) 1992-01-01
IL98499A0 (en) 1992-07-15
IS3718A7 (is) 1991-12-19
ZA914202B (en) 1992-03-25
AU7846991A (en) 1992-01-02
CA2044694A1 (en) 1991-12-19
NO912346D0 (no) 1991-06-17
EP0462522A1 (en) 1991-12-27
LTIP863A (en) 1995-03-27
HUT58069A (en) 1992-01-28
PT98007A (pt) 1992-03-31
NZ238552A (en) 1993-08-26
NO912346L (no) 1991-12-19
CS182991A3 (en) 1992-04-15
KR920000746A (ko) 1992-01-29
MC2263A1 (fr) 1993-04-26
US5141735A (en) 1992-08-25
BR9102489A (pt) 1992-01-21
HU912005D0 (en) 1991-12-30
IE912061A1 (en) 1991-12-18

Similar Documents

Publication Publication Date Title
MX24568A (es) 3-arilcarbonil-1h-indoles y procedimiento para su preparacion.
MX174176B (es) Compuestos azo y procedimiento para su preparacion
MX9205032A (es) 1,2-dihidro-2-oxo-piridinas y procedimiento para su preparacion.
MX9845A (es) Propanaminas 3-ariloxi-3-substituidas y procedimiento para su preparacion.
MX10621A (es) Compuestos de piperazinil heterociclicos y procedimiento para su preparacion.
MX7372A (es) Drivados de tetrahidronaftalina e indano y procedimiento para su preparacion.
MX26267A (es) Aminobenzodiacepinas y procedimiento para su prepaacion.
MX9201355A (es) Bis-naftal imidas y metodo para su preparacion.
MX16687A (es) Compuestos de biarilo y procedimiento para su preparacion.
MX14910A (es) 2',3' -dideoxi-2',2'-difluoronucleosidos y procedimiento para su preparacion.
MX15701A (es) Composiciones de macrolidas y procedimiento para su preparacion.
MX9204920A (es) Cianofenilpirroles y procedimiento para su obtencion.
MX9201780A (es) Eteres oximicos y procedimiento para su preparacion.
MX22255A (es) Compuestos de piridinil-quinolona y procedimiento para su preparacion.
MX9100845A (es) Nuevas tienodiazepinas y procedimiento para su preparacion
MX21243A (es) Indenoindoles y procedimiento para su preparacion.
MX9100415A (es) Piridinas substituidas y procedimiento para su obtencion
MX9102630A (es) Derivados de benzamida y proceso para su preparacion.
MX9205747A (es) Pirazolinas y procedimiento para su preparacion.
MX9100743A (es) Compuestos heterociclicos y procedimiento para su preparacion
MX9100811A (es) Indolonaftiridinas y procedimiento para su preparacion
MX9205746A (es) Pirazolinas y procedimiento para su preparacion.
MX9205821A (es) Pirimidinil- y triazinileteres y -tioeteres y procedimiento para su preparacion.
MX9102583A (es) Microgranallas para vidriado y procedimiento para su obtencion.
MX9202536A (es) Antibioticos tetraciclicos y procedimiento para su preparacion.